Mechanisms and therapeutic potential of microRNAs in hypertension

Drug Discovery Today

Volumn 20, Issue 10, 2015, Pages 1188-1204

  Shi, Lijun ^a   Liao, Jingwen ^a   Liu, Bailin ^a   Zeng, Fanxing ^a   Zhang, Lubo ^b  

^a BEIJING SPORT UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 100; MICRORNA 124; MICRORNA 126; MICRORNA 132; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 17; MICRORNA 193; MICRORNA 19A; MICRORNA 206; MICRORNA 21; MICRORNA 210; MICRORNA 22; MICRORNA 221; MICRORNA 222; MICRORNA 24; MICRORNA 26A; MICRORNA 322; MICRORNA 382; MICRORNA 410; MICRORNA 424; MICRORNA 487; MICRORNA 608; MICRORNA 666; MICRORNA 708; MICRORNA 92; UNCLASSIFIED DRUG; UNINDEXED DRUG;

3' UNTRANSLATED REGION; ANXIETY; BIOGENESIS; BLOOD VESSEL TONE; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIUM CELL; FIBROBLAST; HEREDITARY HYPERTENSION; HUMAN; HYPERTENSION; KINESIOTHERAPY; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PREGNANCY; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REVIEW; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; GENETICS; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR;

ANIMALS; EXERCISE THERAPY; HUMANS; HYPERTENSION; MICRORNAS; RISK FACTORS;

EID: 84944514709     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.05.007     Document Type: Review

References (196)

1. O.A. Carretero, and S. Oparil Essential hypertension. Part I: definition and etiology Circulation 101 2000 329 335
2. N. Kosaka, and et al. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis Cancer Sci. 101 2010 2087 2092
3. D.C. Yu, and et al. Circulating microRNAs: potential biomarkers for cancer Int. J. Mol. Sci. 12 2011 2055 2063
4. R.C. Lee, and et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
5. A. Eulalio, and et al. Getting to the root of miRNA-mediated gene silencing Cell 132 2008 9 14
6. F. Fazi, and C. Nervi MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination Cardiovasc. Res. 79 2008 553 561
7. E.V. Makeyev, and T. Maniatis Multilevel regulation of gene expression by microRNAs Science 319 2008 1789 1790
8. M.A. Song, and et al. Differential expression of microRNAs in ischemic heart disease Drug Discov. Today 20 2015 223 235
9. M. Lagos-Quintana, and et al. Identification of novel genes coding for small expressed RNAs Science 294 2001 853 858
10. Y. Lee, and et al. MicroRNA maturation: stepwise processing and subcellular localization EMBO J. 21 2002 4663 4670
11. A. Rodriguez, and et al. Identification of mammalian microRNA host genes and transcription units Genome Res. 14 2004 1902 1910
12. H.J. Jung, and Y. Suh MicroRNA in aging: from discovery to biology Curr. Genomics 13 2012 548 557
13. E.J. Sontheimer Assembly and function of RNA silencing complexes Nat. Rev. Mol. Cell Biol. 6 2005 127 138
14. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
15. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
16. M. Yamakuchi MicroRNAs in vascular biology Int. J. Vasc. Med. 2012 2012 794898
17. W. Filipowicz, and et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9 2008 102 114
18. R.C. Friedman, and et al. Most mammalian mRNAs are conserved targets of microRNAs Genome Res. 19 2009 92 105
19. Y. Zhao, and et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 Cell 129 2007 303 317
20. A. Saxena, and C.J. Tabin miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation Proc. Natl. Acad. Sci. U. S. A. 107 2010 87 91
21. Y. Peng, and et al. Critical roles of miRNA-mediated regulation of TGFbeta signalling during mouse cardiogenesis Cardiovasc. Res. 103 2014 258 267
22. J.F. Chen, and et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure Proc. Natl. Acad. Sci. U. S. A. 105 2008 2111 2116
23. P.A. da Costa Martins, and et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling Circulation 118 2008 1567 1576
24. D. Wang, and et al. MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts Circ. Res. 114 2014 67 78
25. P.K. Rao, and et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure Circ. Res. 105 2009 585 594
26. Y. Zhao, and et al. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis Nature 436 2005 214 220
27. A. Heidersbach, and et al. microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart Elife 2 2013 e01323
28. Y. Wei, and et al. Multifaceted roles of miR-1s in repressing the fetal gene program in the heart Cell Res. 24 2014 278 292
29. N. Liu, and et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart Genes Dev. 22 2008 3242 3254
30. K. Wystub, and et al. miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development PLoS Genet. 9 2013 e1003793
31. S. Albinsson, and et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function Arterioscler. Thromb. Vasc. Biol. 30 2010 1118 1126
32. Y. Pan, and et al. Conditional deletion of Dicer in vascular smooth muscle cells leads to the developmental delay and embryonic mortality Biochem. Biophys. Res. Commun. 408 2011 369 374
33. S. Albinsson, and et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function PLoS One 6 2011 e18869
34. Z. Chen, and et al. DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice J. Biol. Chem. 287 2012 19018 19028
35. K.R. Cordes, and et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 460 2009 705 710
36. Y. Cheng, and et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation Circ. Res. 105 2009 158 166
37. T. Boettger, and et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster J. Clin. Invest. 119 2009 2634 2647
38. L. Elia, and et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease Cell Death Differ. 16 2009 1590 1598
39. M. Xin, and et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury Genes Dev. 23 2009 2166 2178
40. L. Guo, and et al. The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-alpha1C Hypertension 59 2012 1006 1013
41. C. Xie, and et al. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4 Stem Cells Dev. 20 2011 205 210
42. J. Chen, and et al. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation Arterioscler. Thromb. Vasc. Biol. 31 2011 368 375
43. D. Torella, and et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo Circ. Res. 109 2011 880 893
44. N. Choe, and et al. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia Atherosclerosis 229 2013 348 355
45. Y.S. Wang, and et al. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation Cardiovasc. Res. 95 2012 517 526
46. E. Merlet, and et al. miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat Cardiovasc. Res. 98 2013 458 468
47. M.H. Kim, and et al. MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1 J. Cell. Biochem. 115 2014 1752 1761
48. K. Kang, and et al. MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells J. Biol. Chem. 288 2013 25414 25427
49. P. Li, and et al. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation Circ. Res. 113 2013 1117 1127
50. R. Ji, and et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation Circ. Res. 100 2007 1579 1588
51. B.N. Davis, and et al. SMAD proteins control DROSHA-mediated microRNA maturation Nature 454 2008 56 61
52. J. Song, and et al. Mechanical stretch modulates microRNA 21 expression, participating in proliferation and apoptosis in cultured human aortic smooth muscle cells PLoS One 7 2012 e47657
53. N.J. Leeper, and et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function J. Cell. Physiol. 226 2011 1035 1043
54. X. Liu, and et al. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia Circ. Res. 104 2009 476 487
55. S.G. Sun, and et al. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation EMBO Rep. 12 2011 56 62
56. J. Fiedler, and et al. Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization Antioxid. Redox. Signal. 21 2014 1167 1176
57. G. Bazzoni, and E. Dejana Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis Physiol. Rev. 84 2004 869 901
58. Y. Suarez, and et al. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells Circ. Res. 100 2007 1164 1173
59. A. Kuehbacher, and et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis Circ. Res. 101 2007 59 68
60. S. Asada, and et al. Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis Am. J. Physiol. Heart Circ. Physiol. 295 2008 H2512 H2521
61. Y. Suarez, and et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis Proc. Natl. Acad. Sci. U. S. A. 105 2008 14082 14087
62. J.E. Fish, and et al. miR-126 regulates angiogenic signaling and vascular integrity Dev. Cell 15 2008 272 284
63. F. Kuhnert, and et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 Development 135 2008 3989 3993
64. S. Wang, and et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis Dev. Cell 15 2008 261 271
65. T.A. Harris, and et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 Proc. Natl. Acad. Sci. U. S. A. 105 2008 1516 1521
66. P. Fasanaro, and et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3 J. Biol. Chem. 283 2008 15878 15883
67. Y. Chen, and D.H. Gorski Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5 Blood 111 2008 1217 1226
68. L. Poliseno, and et al. MicroRNAs modulate the angiogenic properties of HUVECs Blood 108 2006 3068 3071
69. C. Iaconetti, and et al. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury Basic Res. Cardiol. 107 2012 296
70. J.M. Daniel, and et al. Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury Cardiovasc. Res. 103 2014 564 572
71. Q. Zhou, and et al. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters Proc. Natl. Acad. Sci. U. S. A. 108 2011 8287 8292
72. R. Kulshreshtha, and et al. A microRNA signature of hypoxia Mol. Cell Biol. 27 2007 1859 1867
73. J. Fiedler, and et al. MicroRNA-24 regulates vascularity after myocardial infarction Circulation 124 2011 720 730
74. X. Qin, and et al. MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells Proc. Natl. Acad. Sci. U. S. A. 107 2010 3240 3244
75. A. Chamorro-Jorganes, and et al. MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 Arterioscler. Thromb. Vasc. Biol. 31 2011 2595 2606
76. S. Grundmann, and et al. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells Circulation 123 2011 999 1009
77. L. Zhang, and et al. MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic pathway Cardiovasc. Drugs Ther. 28 2014 303 311
78. C. Kwon, and et al. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling Proc. Natl. Acad. Sci. U. S. A. 102 2005 18986 18991
79. B. Yang, and et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 Nat. Med. 13 2007 486 491
80. A. Curcio, and et al. MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts PLoS One 8 2013 e70158
81. S. Ikeda, and et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes Mol. Cell Biol. 29 2009 2193 2204
82. T. Takaya, and et al. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells Circ. J. 73 2009 1492 1497
83. X. Luo, and et al. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation J. Clin. Invest. 123 2013 1939 1951
84. A. Care, and et al. MicroRNA-133 controls cardiac hypertrophy Nat. Med. 13 2007 613 618
85. T. Horie, and et al. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes Biochem. Biophys. Res. Commun. 389 2009 315 320
86. T.E. Callis, and et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J. Clin. Invest. 119 2009 2772 2786
87. E. van Rooij, and et al. Control of stress-dependent cardiac growth and gene expression by a microRNA Science 316 2007 575 579
88. E. van Rooij, and et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance Dev. Cell 17 2009 662 673
89. C.E. Grueter, and et al. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13 Cell 149 2012 671 683
90. A. Ventura, and et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters Cell 132 2008 875 886
91. J. Wang, and et al. Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism Dev. Cell 19 2010 903 912
92. E.R. Porrello, and et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes Circ. Res. 109 2011 670 679
93. H. Nishi, and et al. MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes J. Biol. Chem. 285 2010 4920 4930
94. T.G. Hullinger, and et al. Inhibition of miR-15 protects against cardiac ischemic injury Circ. Res. 110 2012 71 81
95. M.C. Chan, and et al. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression EMBO J. 29 2010 559 573
96. M.C. Chan, and et al. A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor Mol. Cell Biol. 27 2007 5776 5789
97. B.N. Davis-Dusenbery, and et al. down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4 J. Biol. Chem. 286 2011 28097 28110
98. H. Huang, and et al. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation J. Biol. Chem. 285 2010 9383 9389
99. C. Doebele, and et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells Blood 115 2010 4944 4950
100. W. Wu, and et al. Flow-dependent regulation of Kruppel-like factor 2 is mediated by microRNA-92a Circulation 124 2011 633 641
101. Y. Fang, and P.F. Davies Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium Arterioscler. Thromb. Vasc. Biol. 32 2012 979 987
102. N. Chen, and et al. MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization PLoS One 9 2014 e95665
103. J.K. Seok, and et al. MicroRNA-382 induced by HIF-1alpha is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog Nucleic Acids Res. 42 2014 8062 8072
104. I. Gorenne, and et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis Circulation 127 2013 386 396
105. K. Fehsel, and et al. Analysis of TNF alpha-induced DNA strand breaks at the single cell level Am. J. Pathol. 139 1991 251 254
106. J. Meloche, and et al. Role for DNA damage signaling in pulmonary arterial hypertension Circulation 129 2014 786 797
107. B. Meyrick, and et al. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study Am. J. Physiol. 239 1980 H692 H702
108. P. Caruso, and et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples Circ. Res. 111 2012 290 300
109. A. Courboulin, and et al. Role for miR-204 in human pulmonary arterial hypertension J. Exp. Med. 208 2011 535 548
110. T. Bertero, and et al. Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension J. Clin. Invest. 124 2014 3514 3528
111. R. Paulin, and et al. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1798 H1809
112. S.S. Pullamsetti, and et al. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension Am. J. Respir. Crit. Care Med. 185 2012 409 419
113. S. Yang, and et al. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling Am. J. Physiol. Lung Cell. Mol. Physiol. 302 2012 L521 L529
114. J. Sarkar, and et al. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L861 L871
115. K.M. Drake, and et al. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8 Am. J. Respir. Crit. Care Med. 184 2011 1400 1408
116. S. Jalali, and et al. Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation PLoS One 7 2012 e46808
117. J. Yue, and et al. MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1alpha/Fhl-1 pathway Lab. Invest. 93 2013 748 759
118. M.W. Chang, and et al. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty J. Clin. Invest. 96 1995 2260 2268
119. S. Sharma, and et al. Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p Circulation 130 2014 776 785
120. F. Shan, and et al. HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia J. Cell. Physiol. 229 2014 1511 1520
121. P. Caruso, and et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline Arterioscler. Thromb. Vasc. Biol. 30 2010 716 723
122. V.N. Parikh, and et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach Circulation 125 2012 1520 1532
123. K. White, and et al. Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis Hypertension 64 2014 185 194
124. J. Kim, and et al. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension Nat. Med. 19 2013 74 82
125. M. Brock, and et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway Circ. Res. 104 2009 1184 1191
126. M. Coen, and et al. Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology Arterioscler. Thromb. Vasc. Biol. 31 2011 2391 2396
127. K.R. Stenmark, and et al. The adventitia: essential regulator of vascular wall structure and function Annu. Rev. Physiol. 75 2013 23 47
128. G. Liu, and et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis J. Exp. Med. 207 2010 1589 1597
129. F. Potus, and et al. Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension Am. J. Respir. Crit. Care Med. 190 2014 318 328
130. A. Zampetaki, and et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circ. Res. 107 2010 810 817
131. S. Meng, and et al. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1 J. Mol. Cell. Cardiol. 53 2012 64 72
132. L. Qiang, and et al. Expression of miR-126 and miR-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients Int. J. Cardiol. 168 2013 2082 2088
133. Y. Fukushima, and et al. Assessment of plasma miRNAs in congestive heart failure Circ. J. 75 2011 336 340
134. S. Li, and et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection Circulation 124 2011 175 184
135. J.E. Kontaraki, and et al. MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage J. Am. Soc. Hypertens. 8 2014 368 375
136. R.S. Friese, and et al. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension Hum. Mol. Genet. 22 2013 3624 3640
137. D. Thabut, and V. Shah Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J. Hepatol. 53 2010 976 980
138. Y. Zhao, and et al. Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway Mol. Cell. Biochem. 359 2012 217 223
139. C.J. Guo, and et al. Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells Apoptosis 14 2009 1331 1340
140. Y. He, and et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4 Cell Signal. 24 2012 1923 1930
141. J. Ji, and et al. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation FEBS Lett. 583 2009 759 766
142. J. Wei, and et al. MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling Biomed. Pharmacother. 67 2013 387 392
143. C.J. Guo, and et al. Dynamic expression of miR-126∗and its effects on proliferation and contraction of hepatic stellate cells FEBS Lett. 587 2013 3792 3801
144. R.C. Huebert, and et al. Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs Am. J. Pathol. 179 2011 1851 1860
145. F.C. Luft, and et al. Genetic influences on the response to dietary salt reduction, acute salt loading, or salt depletion in humans J. Cardiovasc. Pharmacol. 12 Suppl. 3 1988 S49 S55
146. H. Naraba, and N. Iwai Assessment of the microRNA system in salt-sensitive hypertension Hypertens. Res. 28 2005 819 826
147. A.Y. Nossent, and et al. SNPs in microRNA binding sites in 3′-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction Am. J. Hypertens. 24 2011 999 1006
148. A.Y. Nossent, and et al. The 14q32 microRNA-487b targets the antiapoptotic insulin receptor substrate 1 in hypertension-induced remodeling of the aorta Ann. Surg. 258 2013 743 751 discussion 752-743
149. G. Ceolotto, and et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives Am. J. Hypertens. 24 2011 241 246
150. M.M. Martin, and et al. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding J. Biol. Chem. 282 2007 24262 24269
151. M.M. Martin, and et al. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts J. Biol. Chem. 281 2006 18277 18284
152. G. Hanin, and et al. Competing targets of microRNA-608 affect anxiety and hypertension Hum. Mol. Genet. 23 2014 4569 4580
153. [No authors listed] Report of the national high blood pressure education program working group on high blood pressure in pregnancy Am. J. Obstet. Gynecol. 183 2000 S1 S22
154. C.W. Redman Current topic: pre-eclampsia and the placenta Placenta 12 1991 301 308
155. B.L. Pineles, and et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia Am. J. Obstet. Gynecol. 196 2007 e261 e266
156. X.M. Zhu, and et al. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies Am. J. Obstet. Gynecol. 200 2009 e661 e667
157. D.A. Enquobahrie, and et al. Placental microRNA expression in pregnancies complicated by preeclampsia Am. J. Obstet. Gynecol. 204 2011 e112 e121
158. K. Mayor-Lynn, and et al. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor Reprod. Sci. 18 2011 46 56
159. D.C. Lee, and et al. miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies Am. J. Pathol. 179 2011 590 602
160. L. Anton, and et al. miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia Am. J. Pathol. 183 2013 1437 1445
161. S. Muralimanoharan, and et al. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia Placenta 33 2012 816 823
162. O. Ishibashi, and et al. Hydroxysteroid (17-beta) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia Hypertension 59 2012 265 273
163. Y. Zhang, and et al. MicroRNA-155 contributes to preeclampsia by down-regulating CYR61 Am. J. Obstet. Gynecol. 202 2010 e461 e467
164. W. Cheng, and et al. microRNA-155 regulates angiotensin II type 1 receptor expression in umbilical vein endothelial cells from severely pre-eclamptic pregnant women Int. J. Mol. Med. 27 2011 393 399
165. G. Fu, and et al. MicroRNA-376c impairs transforming growth factor-beta and nodal signaling to promote trophoblast cell proliferation and invasion Hypertension 61 2013 864 872
166. J.P. Fisher, and P.J. Fadel Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension Exp. Physiol. 95 2010 572 580
167. Z.D. Fan, and et al. Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats Gene Ther. 19 2012 810 817
168. N.L. Oliveira, and et al. The effects of exercise training on arterial stiffness in coronary artery disease patients: a state-of-the-art review Clin. Physiol. Funct. Imaging 34 2014 254 262
169. F. Ribeiro, and et al. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int. J. Cardiol. 141 2010 214 221
170. S. Gielen, and et al. Exercise training in coronary artery disease and coronary vasomotion Circulation 103 2001 E1 E6
171. A. Linke, and et al. Exercise and the coronary circulation-alterations and adaptations in coronary artery disease Prog. Cardiovasc. Dis. 48 2006 270 284
172. F. Ribeiro, and et al. Effects of exercise training on endothelial progenitor cells in cardiovascular disease: a systematic review Am. J. Phys. Med. Rehabil. 92 2013 1020 1030
173. F. Ribeiro, and et al. Exercise training in the management of patients with resistant hypertension World J. Cardiol. 7 2015 47 51
174. J. Oliveira, and et al. Postaerobic exercise blood pressure reduction in very old persons with hypertension J. Geriatr. Phys. Ther. 2015 PMID: 25760278
175. R. Hambrecht, and et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase Circulation 107 2003 3152 3158
176. M.H. Laughlin, and et al. Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype J. Appl. Physiol. (1985) 104 2008 588 600
177. M. Weber, and et al. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity Biochem. Biophys. Res. Commun. 393 2010 643 648
178. J. Zhou, and et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation Proc. Natl. Acad. Sci. U. S. A. 108 2011 10355 10360
179. J. He, and et al. The feedback regulation of PI3K-miR-19a, and MAPK-miR-23b/27b in endothelial cells under shear stress Molecules 18 2012 1 13
180. J.S. Mohamed, and et al. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta J. Biol. Chem. 285 2010 29336 29347
181. B. Hu, and et al. Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype PLoS One 9 2014 e96338
182. X.D. Wu, and et al. Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis Int. J. Sports. Med. 35 2014 344 350
183. N.D. Da Silva Jr., and et al. Swimming training in rats increases cardiac microRNA-126 expression and angiogenesis Med. Sci. Sports Exerc. 44 2012 1453 1462
184. A.S. Greene, and et al. Microvascular rarefaction and tissue vascular resistance in hypertension Am. J. Physiol. 256 1989 H126 H131
185. R.M. Melo, and et al. Training-induced, pressure-lowering effect in SHR: wide effects on circulatory profile of exercised and nonexercised muscles Hypertension 42 2003 851 857
186. T. Fernandes, and et al. Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16, -21, and -126 Hypertension 59 2012 513 520
187. P.S. Mitchell, and et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. U. S. A. 105 2008 10513 10518
188. A.J. Tijsen, and et al. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases Am. J. Physiol. Heart Circ. Physiol. 303 2012 H1085 H1095
189. A.S. Sayed, and et al. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases Heart Lung Circ. 23 2014 503 510
190. Q. Yang, and et al. MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation Int. J. Cardiol. 177 2014 925 934
191. I. Hromadnikova, and et al. First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension PLoS One 9 2014 e113735
192. L. Guo, and et al. Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic pulmonary hypertension PLoS One 9 2014 e101055
193. K.L. Burgos, and et al. Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing RNA 19 2013 712 722
194. I. Sanders, and et al. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma Int. J. Urol. 19 2012 1017 1025
195. E. van Rooij The art of microRNA research Circ. Res. 108 2011 219 234
196. A. Valoczi, and et al. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes Nucleic Acids Res. 32 2004 e175